Song, Ling
Zhang, Yi
Jiang, Ji
Ren, Shuang
Chen, Li
Liu, Dongyang
Chen, Xijing
Hu, Pei
Funding for this research was provided by:
National Natural Science Foundation of China (81403013, 81403015)
"13th Five-Year" National Major New Drug Projects (2017ZX09101001-002-001, 2017ZX09304031-001)
Article History
First Online: 6 April 2018
Compliance with Ethical Standards
:
: Yi Zhang, Shuang Ren, and Li Chen are employees of Hua Medicine (Shanghai) Ltd., the company developing sinogliatin. Ling Song, Ji Jiang, Dongyang Liu, Xijing Chen, and Pei Hu declare no conflicts of interest relevant to the contents of this manuscript.